Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011;16 Suppl 2(Suppl 2):1-3.
doi: 10.1634/theoncologist.2011-S2-01.

New perspectives on the treatment of metastatic renal cell carcinoma: an introduction and historical overview

Affiliations

New perspectives on the treatment of metastatic renal cell carcinoma: an introduction and historical overview

Robert J Motzer. Oncologist. 2011.

Abstract

The content of the supplement is summarized, including a review of the pathogenesis and diagnosis of renal cell carcinoma and the efficacy and safety of the currently available targeted therapies.

PubMed Disclaimer

Conflict of interest statement

Disclosures: Robert J. Motzer: Honoraria: Eisai, Bristol-Myers Squibb; Research funding/contracted research: GlaxoSmithKline, Novartis, Pfizer.

The content of this article has been reviewed by independent peer reviewers to ensure that it is balanced, objective, and free from commercial bias. No financial relationships relevant to the content of this article have been disclosed by the independent peer reviewers.

Figures

Figure 1.
Figure 1.
Timeline of treatments for renal cell carcinoma. Abbreviations: EMA, European Medicines Agency; FDA, U.S. Food and Drug Administration; IFN, interferon; IL, interleukin.

References

    1. American Cancer Society. Atlanta: American Cancer Society; 2010. [accessed August 25, 2010]. Cancer Facts & Figures 2010. Available at http://www.cancer.org/acs/groups/content/@nho/documents/document/acspc-0....
    1. Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med. 2005;353:2477–2490. - PubMed
    1. NCCN Clinical Practice Guidelines in Oncology™ Kidney Cancer. [accessed July 30, 2010]. Version 2.2010. ©2009 National Comprehensive Cancer Network, Inc. Available at http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site.
    1. Altekruse SF, Kosary CL, Krapcho M, et al., editors. Bethesda, MD: National Cancer Institute; [accessed July 30, 2010]. SEER Stat Fact Sheets: Kidney and Renal Pelvis. SEER Cancer Statistics Review, 1975–2007. Available at http://seer.cancer.gov/csr/1975_2007.
    1. Belldegrun AS, Klatte T, Shuch B, et al. Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989–2005): A benchmark for emerging targeted cancer therapies. Cancer. 2008;113:2457–2463. - PubMed

Publication types

MeSH terms